Clinical Trials Directory

Trials / Completed

CompletedNCT01699919

A Study to Assess Analgesic Efficacy of Intravenous Lignocaine

Effect of Perioperative Systemic Lignocaine on Postoperative Pain in Patients Undergoing Elective Open Abdominal Surgeries- a Double Blinded Randomized Control Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objectives of this study are to analyse the effect of perioperative systemic infusion of lignocaine on postoperative pain, postoperative nausea and vomiting and perioperative levels of inflammatory mediators in patients undergoing elective open abdominal surgeries. The secondary parameters which will be observed during the study are the time to passage of flatus and stools postoperatively.

Detailed description

Patients will be randomized into two groups- A and B, to receive an intravenous infusion of lignocaine or saline,respectively, as a bolus of 1.5mg/kg at the time of intubation followed by an infusion at a rate of 1.5mg/kg/hr continued throughout the surgery and till one hour postop. Postoperative analgesia will be provided through Patient Controlled Analgesia (PCA) pump providing morphine. Postoperative pain scores will be noted at immediate postoperative and at 6, 18, 24 hours post surgery. The number of PCA demands and cumulative morphine consumption till 24 hours post surgery will be noted. The incidence of postoperative nausea and vomiting is recorded. The time to first passage of flatus and stools postoperatively will be noted. Levels of total leukocyte count, c-reactive protein (CRP) and interleukin-6(IL-6) will be noted in preoperative, immediate post operative and 24 hours post surgery.

Conditions

Interventions

TypeNameDescription
DRUGIntravenous lignocaineIntravenous lignocaine infusion is given in intraoperative period and till one hour post surgery.

Timeline

Start date
2011-04-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2012-10-04
Last updated
2012-10-04

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01699919. Inclusion in this directory is not an endorsement.